Mumbai: India’s largest drugmaker Sun Pharmaceutical has received a nod from the US Food and Drug Administration (USFDA) to expand the therapeutic use of its innovative drug Ilumya for ...
Sun Pharmaceutical Industries on Monday said it has launched its global innovative drug ILUMYA in India for the treatment of moderate-to-severe plaque psoriasis. A novel biologic treatment, ILUMYA (Tildrakizumab) ...